Related Experiment Video
Updated: May 4, 2026

Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies
Published on: April 5, 2024
Adiponectin and the cardiometabolic syndrome: an epidemiological perspective
Tohru Funahashi1, Yuji Matsuzawa2
1Department of Metabolism and Atherosclerosis, Osaka University Graduate School of Medicine, 2-2 B5 Yamadaoka, Suita, Osaka 565-0871, Japan.
Abstract:
Adiponectin is an adipocyte-derived plasma protein with cardio-vasculo-protective and anti-diabetic properties. Plasma adiponectin levels are low in patients with the cardiometabolic syndrome (a cluster of multiple risk factors based on visceral fat accumulation). Routine measurement of plasma adiponectin may be useful to encourage life-style changes.
More Related Videos
10:40Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro
Published on: December 5, 2025
02:55Author Spotlight: Illuminating New Avenues for Adipose Tissue Metabolism and Disease Prevention
Published on: October 6, 2023
Related Concept Videos
Coronary Artery Disease I: Introduction
Obesity
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Hypertension II: Pathophysiology